4//SEC Filing
Coulie Bernard 4
Accession 0001209191-23-021915
CIK 0001746473other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:54 PM ET
Size
6.5 KB
Accession
0001209191-23-021915
Insider Transaction Report
Form 4
Coulie Bernard
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-03-29+68,749→ 310,092 total
Holdings
- 409,317(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]On July 28, 2022, the Reporting Person was granted 275,000 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On March 29, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 68,749 shares.
- [F2]Includes 1,231 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
- [F3]Shares are held by The Coulie/Leyman Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001808895
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 5:54 PM ET
- Size
- 6.5 KB